Albemarle Corporation

ALB Basic Materials Specialty Chemicals

Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

95.48 2.70 −2.75%
Market cap
$11.6B
P/E
199×
Fwd P/E
14.9×
Dividend yield
1.70%
F-score
6/9
Altman Z
2.31
Beneish M
−3.71
Dividend safety
47/100

Insider Decisions trades per month

Total sells 7.35
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — 2 1 — 1 — — — — —
Insider Ownership 0.23%

Capital & Financial Ratios $m

Market Cap 11,590.00
Revenue 5,907.90
Net Income 278.49
Free Cash Flow 1,351.43
Net Debt 245.10
Current Ratio 2.09 (at or above 1.5: strong)
Debt/Equity 0.18 (at or below 0.5: strong)
P/E ratio 198.92 (above 35: high)
Fwd P/E 14.90
P/S ratio 1.91
P/B ratio 1.36
Past 5Y EPS Growth —
This Y EPS Growth 1,531.50% (at or above 15%: strong)
Next Y EPS Growth (9.60%) (below 0%: weak)
Next Y revenue growth 19.00% (at or above 10%: strong)
Next 5Y EPS Growth (6.21%) (below 0%: weak)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 92.91%
10-year low 10-year high
P/S against its own 10 years 18.25%
10-year low 10-year high
P/B against its own 10 years 10.87%
10-year low 10-year high
EV/Sales against its own 10 years 10.03%
10-year low 10-year high
EV/FCF against its own 10 years 0.08%
10-year low 10-year high

Dividends

Payout Ratio 6.02
Annual Dividend Rate 1.63
Annual Dividend Yield 1.70%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 1.62
0.41
0.41
0.41
2025 1.62
0.41
0.41
0.41
0.41
2024 1.61
0.40
0.40
0.41
0.41
2023 1.60
0.40
0.40
0.40
0.40
2022 1.58
0.40
0.40
0.40
0.40
2021 1.56
0.39
0.39
0.39
0.39
2020 1.54
0.39
0.39
0.39
0.39
2019 1.47
0.37
0.37
0.37
0.37
2018 1.34
0.34
0.34
0.34
0.34
2017 1.28
0.32
0.32
0.32
0.32
2016 1.22
0.31
0.31
0.31
0.31
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 890 1,192 1,618 1,632
Receivables 1,722 981 699 728
Inventory 2,161 1,503 1,179 1,385
Other 443 167 512 200
5,217 3,842 4,008 3,944
2023 2024 2025 Q'26
Payables 2,088 944 914 1,116
ST’ Debt 626 398 74 75
Other — — 192 —
3,560 1,966 1,798 1,891

Compound Annual Growth %

10y 5y 3y
Sales 6.17% 10.45% (11.10%)
Cash Flow 13.52% 9.92% (12.41%)
Earnings 0.00% 0.00% 0.00%
Book Value 11.14% 16.96% 6.09%

Revenue $m

Mar Jun Sep Dec Year
’26 1,429 1,743 — — —
’25 1,077 1,330 1,308 1,428 5,143
’24 1,361 1,430 1,355 1,232 5,378
’23 2,580 2,370 2,311 2,356 9,617
’22 1,128 1,480 2,092 2,621 7,320
’21 829 774 831 894 3,328
’20 739 764 747 879 3,129
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 346 710 — — —
’25 547 (9) 356 388 1,282
’24 98 367 227 (4) 688
’23 721 74 629 (97) 1,327
’22 206 (146) 895 952 1,908
’21 158 228 105 (146) 344
’20 155 53 254 337 799
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 248 638 — — —
’25 365 (105) 225 240 725
’24 (481) (88) (76) (318) (964)
’23 305 (430) 83 (786) (828)
’22 (26) (417) 582 507 646
’21 (22) 11 (151) (447) (609)
’20 (59) (152) 51 108 (52)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 2.34 3.52 — — —
’25 0.00 (0.16) (1.72) (3.87) (5.76)
’24 (0.08) (1.96) (9.45) 0.29 (11.20)
’23 10.51 5.52 2.57 (5.26) 13.36
’22 2.15 3.46 7.61 9.60 22.84
’21 0.84 3.62 (3.36) (0.03) 1.06
’20 1.01 0.80 0.92 0.79 3.52
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 45.78 86.98 71.89 58.63 48.89 133.82 169.93 112.00 71.97 49.43

Analyst estimates 2026–2028

Powerpack
High 92.24 144.99 138.67 93.14 153.48 291.48 334.55 293.01 149.61 152.08
People
People Employees 5,000 5,400 5,900 6,000 5,900 6,000 7,400 9,000 8,300 7,800
Revenue/emp, $m 0.54 0.57 0.57 0.60 0.53 0.55 0.99 1.07 0.65 0.66
Income, $m
Income, $m Revenue 2,677 3,072 3,375 3,589 3,129 3,328 7,320 9,617 5,378 5,143
Gross margin, % 36.24 36.01 36.07 35.04 31.80 29.99 42.00 12.33 1.16 13.00
EBT 515 447 795 563 374 134 2,433 247 (1,764) (552)
EBT margin, % 19.25 14.54 23.55 15.68 11.94 4.02 33.24 2.57 (32.80) (10.74)
Net income 681 99 739 604 447 200 2,815 1,671 (1,135) (465)
Depreciation 226 197 201 213 232 254 301 430 589 840
Per share, $
Per share, $ Revenue 23.82 27.70 31.13 33.88 29.41 28.73 62.50 81.98 45.76 43.71
Earnings 5.73 0.49 6.40 5.03 3.53 1.07 22.97 13.41 (11.20) (5.76)
Cash flow 6.55 2.74 5.04 6.79 7.51 2.97 16.29 11.31 5.85 10.90
Capex (1.75) (2.86) (6.46) (7.94) (7.99) (8.23) (10.77) (18.37) (14.05) (4.73)
Free cash flow 4.80 (0.12) (1.42) (1.15) (0.48) (5.26) 5.52 (7.06) (8.20) 6.16
Book value 35.08 34.42 34.67 38.64 42.00 50.12 69.94 82.38 86.79 83.13
Shares, m 112 111 108 106 106 116 117 117 118 118
Valuation, ×
Valuation, × P/E 15.39 274.02 12.08 14.52 41.79 214.47 9.34 10.94 0.00 0.00
P/S 3.70 4.75 2.48 2.16 5.02 8.14 3.43 1.79 1.88 3.24
P/B 2.51 3.82 2.22 1.89 3.51 4.66 3.07 1.78 1.27 2.21
EV/Sales 3.73 4.98 2.82 2.83 5.92 8.72 3.67 2.13 2.31 3.54
EV/FCF 18.55 (1,114.00) (61.80) (83.36) (359.21) (47.64) 41.54 (24.77) (12.91) 25.12
Cash, $m
Cash, $m Operating cash flow 736 304 546 719 799 344 1,908 1,327 688 1,282
Capex (197) (318) (700) (841) (850) (954) (1,262) (2,155) (1,651) (557)
Free cash flow 539 (14) (154) (122) (52) (609) 646 (828) (964) 725
Balance, $m
Balance, $m Working capital 2,167 1,277 815 816 404 119 2,446 1,656 1,876 2,210
Total debt 2,369 1,837 1,705 3,050 3,572 2,394 3,217 4,167 3,516 3,194
Net debt 100 700 1,150 2,437 2,825 1,955 1,718 3,277 2,324 1,576
Shareholders’ equity 3,943 3,818 3,759 4,094 4,469 5,806 8,191 9,665 10,200 9,781
Returns, %
Returns, % ROA 7.25 0.69 9.05 6.11 3.70 1.15 20.35 9.33 (7.55) (4.11)
ROIC 9.29 7.91 11.61 6.37 4.33 6.43 15.58 1.22 (8.87) (2.02)
ROE 17.53 1.41 18.31 13.58 8.78 2.41 38.44 17.62 (14.93) (8.73)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Albemarle Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DD DuPont de Nemours, Inc. $17.8B 290× 26.5× +4.00% (above 0%: growing) +150.00% (above 0%: growing) +1,250.00% (above 0%: growing) 35.13% 16.38% Compare
RPM RPM International Inc. $12.8B 18.4× 18.3× +4.82% (above 0%: growing) +13.75% (above 0%: growing) +33.14% (above 0%: growing) 41.25% 15.99% Compare
ALB Albemarle Corporation $11.6B 199× 14.9× +31.08% (above 0%: growing) n/m +708.43% (above 0%: growing) 33.86% 25.98%
SSL Sasol Ltd. $10.1B 3.5× 5.2× −5.20% (below 0%: shrinking) +20.86% (above 0%: growing) +6,912.65% (above 0%: growing) 31.35% 0.00% Compare
SOLS Solstice Advanced Materials Inc. $9.5B 27.4× 27.8× +11.13% (above 0%: growing) −14.99% (below 0%: shrinking) +70.83% (above 0%: growing) 32.23% 17.16% Compare
ESI Element Solutions Inc. $8.7B 47.4× 33.3× +56.41% (above 0%: growing) +60.00% (above 0%: growing) +29.19% (above 0%: growing) 34.15% 11.63% Compare
SQM Sociedad Quimica y Minera S.A. $8.6B 11.3× 12.1× +138.12% (above 0%: growing) +381.25% (above 0%: growing) −63.75% (below 0%: shrinking) 51.05% 48.62% Compare
NEU NewMarket Corporation $8.2B 18.8× — (loss-making) +6.96% (above 0%: growing) +22.80% (above 0%: growing) −6.94% (below 0%: shrinking) 32.45% 21.91% Compare
WLK Westlake Corporation $8.1B — (loss-making) 24.8× +10.77% (above 0%: growing) n/m +184.09% (above 0%: growing) 19.93% 11.13% Compare
Median of peers $9.1B 18.8× 24.8× +8.87% +22.80% +51.99% 33.30% 16.19%

All 60 Specialty Chemicals stocks →

ALB metrics, ten years each

Albemarle Corporation (ALB) key facts

  • Concern: Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
  • Albemarle Corporation (ALB) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, ALB traded at $95.48, a market capitalization of $11.6 billion.
  • Albemarle Corporation pays an annual dividend of $1.63 per share, a yield of 1.70%.
  • Return on equity was −8.73% and debt-to-equity 0.18.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 2.31 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Albemarle Corporation (ALB) Latest News

3 Sep

13 Aug

Impact 3 · transcript
stockrow.com/ALB · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com